TCGA-62-A46V-01A-11R-A24H-07
— · cohortA1
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- cohortA1
- subtype
- cohortA1
- age_years
- 78
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- COAGULATION+0.210
- MYOGENESIS+0.210
- FATTY_ACID_METABOLISM+0.180
- PEROXISOME+0.150
- BILE_ACID_METABOLISM+0.120
- ADIPOGENESIS+0.110
- XENOBIOTIC_METABOLISM+0.110
- EPITHELIAL_MESENCHYMAL_TRANSITION+0.060
- APICAL_JUNCTION+0.050
- PANCREAS_BETA_CELLS+0.040
Top 10 suppressed
- E2F_TARGETS-0.470
- G2M_CHECKPOINT-0.440
- MYC_TARGETS_V2-0.430
- TGF_BETA_SIGNALING-0.410
- INTERFERON_GAMMA_RESPONSE-0.400
- TNFA_SIGNALING_VIA_NFKB-0.400
- ALLOGRAFT_REJECTION-0.390
- MYC_TARGETS_V1-0.390
- INFLAMMATORY_RESPONSE-0.350
- MTORC1_SIGNALING-0.350
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
9 twins match this tumor's tissue · 1 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | TCGA-97-8179-01A-11R-2287-07 | — | cohortA2 | 0.843 |
| 2 | TCGA-78-7149-01A-11R-2039-07 | — | cohortA2 | 0.840 |
| 3 | SJEPD001522_R1.RNA-Seq | EPN | EPN Tumor | 0.838 |
| 4 | MBCProject_3946_T4_RNA | — | A | 0.833 |
| 5 | SRR2700736 | — | — | 0.832 |
| 6 | TCGA-NJ-A55R-01A-11R-A262-07 | — | cohortA3 | 0.821 |
| 7 | 3d1f44d8-6084-47cb-b57b-099f2cd1fa0e | — | — | 0.819 |
| 8 | C3L-03726 | — | cohortA2 | 0.818 |
| 9 | SRR1313097 | — | A | 0.816 |
| 10 | SRR12202450 | — | — | 0.815 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 10 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| COAGULATION | 0.210 | Binimetinib | — uncovered |
| MYOGENESIS | 0.210 | Inavolisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.180 | Inavolisib | — uncovered |
| PEROXISOME | 0.150 | Idelalisib | — uncovered |
| BILE_ACID_METABOLISM | 0.120 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.110 | Inavolisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.110 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.060 | Inavolisib | — uncovered |
| APICAL_JUNCTION | 0.050 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.040 | Cobimetinib | — uncovered |